11 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 26893443 | Intraoperative Hydroxyethyl Starch and its Effects on Different Fibrinogen Measurements. | 2016 Oct | 3 |
2 | 26603798 | The effects of haemodilution with hydroxyethyl starch 130/0.4 solution on coagulation as assessed by thromboelastography and platelet receptor function studies in vitro. | 2015 Nov | 3 |
3 | 19617247 | Influence of different hydroxyethyl starch (HES) formulations on fibrinogen measurement in HES-diluted plasma. | 2010 Aug | 4 |
4 | 20056447 | Profound effects of cardiopulmonary bypass priming solutions on the fibrin part of clot formation: an ex vivo evaluation using rotation thromboelastometry. | 2010 Jun | 2 |
5 | 15608046 | Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate. | 2005 Mar | 2 |
6 | 16095459 | Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions. | 2005 Sep | 1 |
7 | 11375812 | The effects of hydroxyethyl starches of varying molecular weights on platelet function. | 2001 Jun | 1 |
8 | 8825225 | Dextran and hydroxyethyl starch interfere with fibrinogen assays. | 1995 Dec | 2 |
9 | 2408362 | Effects of hydroxyethyl starch on fibrinogen, fibrin clot formation, and fibrinolysis. | 1985 May-Jun | 1 |
10 | 2411030 | Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII. | 1985 Jul-Aug | 1 |
11 | 6197944 | Hydroxyethyl starch versus albumin for colloid infusion following cardiopulmonary bypass in patients undergoing myocardial revascularization. | 1984 Jan | 1 |